Key Benefits: Illuminates and unifies skin tone Visibly reduces spots, pigmentation and irregularities Improves elasticity and firmness, combating wrinkles and fine lines Intensely hydrates and leaves skin with a long-lasting healthy glow Light and fast-absorbing texture Suitable for daily use and all skin types, even the most sensitive Suitable for all skin types, especially: Skin with blemishes, uneven or dull tone
Boehringer Ingelheim is solely responsible for further development and global commercialization
Currently available GLP-1 receptor agonists in the UK include: For type 2 diabetes : semaglutide (Ozempic [injection], Rybelsus [oral tablet]), dulaglutide (Trulicity), liraglutide (Victoza), exenatide (Byetta, Bydureon), and lixisenatide (Lyxumia) For weight management : semaglutide 2.4 mg (Wegovy) and liraglutide 3 mg (Saxenda) Most GLP-1 medications are administered via subcutaneous injection, with dosing frequencies ranging from daily to once weekly depending on the specific formulation
The following common conditions do disqualify the person from donating blood as the donated blood may cause harm to the receiver: planning for an HIV, Human T-cell lymphotropic virus (HTLV) or Hepatitis test with HIV positive a hepatitis B carrier a hepatitis C carrier with HTLV positive already treated for syphilis ever worked as commercial sex worker ever injected with drugs in the recent past or long ago A consultation is also required to ensure the eligibility of the person
